Network building

Adequate Daclatasvir exposures in children 14-35 Kg with available adult formulations

30 Apr, 2021

Authors: Cressey RT, Abbassi M, Lallemant M, Indolfi G, Al-Nahari M, Farid S, Easterbrook P, Penazzato M,  El-Sayed HM Published in: CROI 2021   Abstract: World Health Organization 2018 guidelines…
Read More

Tools for Healthcare Workers to measure Health Research Capacity Development at an Individual Level

19 Nov, 2020

  Author: Bilardi D, Rapa E, Bernays S, & Lang T Published in: European Academy of Pediatric Societies   Background: Despite health research capacity development (HRCD) in low and middle-income…
Read More

European research networks to facilitate drug research in children

16 Oct, 2020

  Author: Mark A. Turner, Katharine Cheng, Saskia de Wildt, Heidrun Hildebrand, Sabah Attar, Paolo Rossi, Donato Bonifazi, Adriana Ceci, Joana Claverol, Begonya Nafria, Carlo Giaquinto Published in: British Journal…
Read More

Harmonisation preserves research resources

29 Jul, 2020

Authors: Vasconcelos MK, Epalza C, Renk H, Tagarro A, Bielicki JA Published in: Lancet Infect Dis. 2020;24 In their Comment, the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)…
Read More

Respiratory pathogens detected in children with community-acquired sepsis-like syndrome in 6 European countries

26 Apr, 2020

Authors: V. Matheeussen, K. Loens, K. Jacobs, P. Horby, H. Goossens, M. Kohns Vasconcelos, M. Sharland, M. De Jong, M. P. G. Koopmans, P. Fraaij, M. Ieven Published in: 30th…
Read More

Aetiology and outcome of children hospitalised for acute respiratory tract infections in Europe: findings from a multi-country combined case-control and cohort study

26 Apr, 2020

Authors: M. Kohns Vasconcelos; on behalf of the PED-MERMAIDS Study Group Published in: 30th European Congress on Clinical Microbiology and Infectious Diseases (ECCMID), April 2020 Background: Recently, major aetiology and outcome…
Read More

Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol

24 Sep, 2019

Authors: Kaguelidou F, Le Roux E, Mangiarini L, et al.; GAPP consortium Published in: BMJ Open. 2019;9(2):e023296 Introduction Gabapentin is currently used ‘off-label’ in children and adolescents with chronic neuropathic pain, and reliable evidence…
Read More

Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years – evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

24 Sep, 2019

Authors: de Leeuw TG, Mangiarini L, Lundin R, et al; GAPP consortium Published in: Trials. 2019; 20(1):368 Background Gabapentin has shown efficacy in the treatment of chronic neuropathic or mixed pain in adults.…
Read More